Concepedia

Seungyeon Jung

SJ

Statistics

Publications

6

Citations

157

H-Index

6

Active since

2018

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

The University of Sydney

Massachusetts General Hospital

Peking University Cancer Hospital

Seungyeon Jung is an author at Vanderbilt University Medical Center specializing in medicine, oncology, and melanoma immunotherapy.

ORCID

Publications per year

2018–2024

6

Publications

6

Microtubule minus-end aster organization is driven by processive HSET-tubulin clusters

Stephen R. Norris, Seungyeon Jung, Prashant K. Singh et al. · Nature Communications · 2018 · 53 citations · Full text

, , +14

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study

Xue Bai, Shaheen Ahmed, Charlotte Grieco et al. · EClinicalMedicine · 2023 · 27 citations · Full text

, , +17

Clinical and genomic correlates of imatinib response in melanomas with KIT alterations

Seungyeon Jung, Emma Armstrong, Alexander Z. Wei et al. · British Journal of Cancer · 2022 · 26 citations · Full text

, , +16

Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study

Eden David, Neda Shokrian, Ester Del Duca et al. · Archives of Dermatological Research · 2024 · 24 citations · Full text

, , +14

Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study

Xue Bai, Aleigha Lawless, Juliane A. Czapla et al. · JAAD International · 2024 · 16 citations · Full text

, , +16

1–5 of 6